Dr. Ed Mascioli
Dr. Ed Mascioli, who has previously served as a senior executive at Pfizer, has been announced as the CEO of Affinium Pharmaceuticals.
The company - who last year licensed spray-dried dispersion technology from Bend Research – has also appointed current President and CEO of Egalet, Bob Radie, onto its Board of Directors.
Dr. Stuart Collinson, Chairman of the Board said: "As we progress past the clinical proof-of-concept stage for our novel antibiotic, Dr. Mascioli and Mr. Radie bring key business development expertise to our current discussions with potential partners."